Literature DB >> 10920207

Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease.

J Carmichael1, J Chatellier, A Woolfson, C Milstein, A R Fersht, D C Rubinsztein.   

Abstract

Huntington's disease (HD) is an autosomal dominant neurodegenerative condition caused by expansions of more than 35 uninterrupted CAG repeats in exon 1 of the huntingtin gene. The CAG repeats in HD and the other seven known diseases caused by CAG codon expansions are translated into long polyglutamine tracts that confer a deleterious gain of function on the mutant proteins. Intraneuronal inclusions comprising aggregates of the relevant mutant proteins are found in the brains of patients with HD and related diseases. It is crucial to determine whether the formation of inclusions is directly pathogenic, because a number of studies have suggested that aggregates may be epiphenomena or even protective. Here, we show that fragments of the bacterial chaperone GroEL and the full-length yeast heat shock protein Hsp104 reduce both aggregate formation and cell death in mammalian cell models of HD, consistent with a causal link between aggregation and pathology.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920207      PMCID: PMC16928          DOI: 10.1073/pnas.170280697

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch.

Authors:  S Igarashi; R Koide; T Shimohata; M Yamada; Y Hayashi; H Takano; H Date; M Oyake; T Sato; A Sato; S Egawa; T Ikeuchi; H Tanaka; R Nakano; K Tanaka; I Hozumi; T Inuzuka; H Takahashi; S Tsuji
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.

Authors:  D Martindale; A Hackam; A Wieczorek; L Ellerby; C Wellington; K McCutcheon; R Singaraja; P Kazemi-Esfarjani; R Devon; S U Kim; D E Bredesen; F Tufaro; M R Hayden
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

4.  Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

Authors:  H L Paulson; M K Perez; Y Trottier; J Q Trojanowski; S H Subramony; S S Das; P Vig; J L Mandel; K H Fischbeck; R N Pittman
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

5.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

6.  The crystal structure of the GroES co-chaperonin at 2.8 A resolution.

Authors:  J F Hunt; A J Weaver; S J Landry; L Gierasch; J Deisenhofer
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

7.  Complex I defect in muscle from patients with Huntington's disease.

Authors:  J Arenas; Y Campos; R Ribacoba; M A Martín; J C Rubio; P Ablanedo; A Cabello
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

8.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture.

Authors:  J K Cooper; G Schilling; M F Peters; W J Herring; A H Sharp; Z Kaminsky; J Masone; F A Khan; M Delanoy; D R Borchelt; V L Dawson; T M Dawson; C A Ross
Journal:  Hum Mol Genet       Date:  1998-05       Impact factor: 6.150

9.  Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.

Authors:  S W Davies; M Turmaine; B A Cozens; M DiFiglia; A H Sharp; C A Ross; E Scherzinger; E E Wanker; L Mangiarini; G P Bates
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

10.  Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures.

Authors:  P J Skinner; B T Koshy; C J Cummings; I A Klement; K Helin; A Servadio; H Y Zoghbi; H T Orr
Journal:  Nature       Date:  1997-10-30       Impact factor: 49.962

View more
  62 in total

1.  Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease.

Authors:  J M Lecerf; T L Shirley; Q Zhu; A Kazantsev; P Amersdorfer; D E Housman; A Messer; J S Huston
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

2.  Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography.

Authors:  M M Altamirano; A Woolfson; A Donda; A Shamshiev; L Briseño-Roa; N W Foster; D B Veprintsev; G De Libero; A R Fersht; C Milstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

Review 3.  Huntington's disease.

Authors:  S Davies; D B Ramsden
Journal:  Mol Pathol       Date:  2001-12

4.  NMNAT suppresses tau-induced neurodegeneration by promoting clearance of hyperphosphorylated tau oligomers in a Drosophila model of tauopathy.

Authors:  Yousuf O Ali; Kai Ruan; R Grace Zhai
Journal:  Hum Mol Genet       Date:  2011-09-30       Impact factor: 6.150

Review 5.  Physical chemistry of polyglutamine: intriguing tales of a monotonous sequence.

Authors:  Ronald Wetzel
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

6.  Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.

Authors:  Trent Kunkle; Sanofar Abdeen; Nilshad Salim; Anne-Marie Ray; Mckayla Stevens; Andrew J Ambrose; José Victorino; Yangshin Park; Quyen Q Hoang; Eli Chapman; Steven M Johnson
Journal:  J Med Chem       Date:  2018-11-15       Impact factor: 7.446

7.  Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity.

Authors:  Megan Krench; J Troy Littleton
Journal:  Fly (Austin)       Date:  2013-09-10       Impact factor: 2.160

8.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

Review 9.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

Review 10.  The ubiquitin-proteasome pathway in Huntington's disease.

Authors:  Steven Finkbeiner; Siddhartha Mitra
Journal:  ScientificWorldJournal       Date:  2008-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.